Outputs (3)

Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies (2018)
Journal Article
Martini, A., Dal Lago, D., Edelstyn, N., Salgarello, M., Lugoboni, F., & Tamburin, S. (2018). Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies. Frontiers in Neurology, https://doi.org/10.3389/fneur.2018.01018

Background Around 30% Parkinson’s disease (PD) patients develop impulse control disorders (ICDs) to D2/3 dopamine agonists and, to a lesser extent, levodopa. We aim to investigate striatal dopaminergic function in PD patients with and without ICD.... Read More about Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies.

Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective and motivational correlates (2018)
Journal Article
Martini, A., Dal Lago, D., Edelstyn, N. M., Grange, J. A., & Tamburin, S. (2018). Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective and motivational correlates. Frontiers in Neurology, https://doi.org/10.3389/fneur.2018.00654

Background In Parkinson’s disease (PD), impulse control disorders (ICDs) develop as side-effect of dopaminergic replacement therapy (DRT). One hypothesis is that DRT overdoses less-severely affected dopamine-modulated circuits on which cognition, aff... Read More about Impulse control disorder in Parkinson's disease: a meta-analysis of cognitive, affective and motivational correlates.

Risky Decision-Making And Affective Features Of Impulse Control Disorders In Parkinson’s Disease (2018)
Journal Article
Martini, A., Ellis, S. J., Grange, J. A., Tamburin, S., Dal Lago, D., Vianello, G., & Edelstyn, N. M. (2018). Risky Decision-Making And Affective Features Of Impulse Control Disorders In Parkinson’s Disease. Journal of Neural Transmission, 131-143. https://doi.org/10.1007/s00702-017-1807-7

Background. Impulse Control Disorders (ICDs) in Parkinson’s disease (PD) are considered dopaminergic treatment side effects. Cognitive and affective factors may increase the risk of ICD in PD. Aims. To investigate risky decision-making and associate... Read More about Risky Decision-Making And Affective Features Of Impulse Control Disorders In Parkinson’s Disease.